Dominik Höchli
Director/Miembro de la Junta en MOLECULAR PARTNERS AG .
Cargos activos de Dominik Höchli
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MOLECULAR PARTNERS AG | Director/Miembro de la Junta | 21/04/2021 | - |
| Independent Dir/Board Member | 21/04/2021 | - | |
Catapult Therapeutics BV
 Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Director Ejecutivo | 01/01/2021 | - |
Historial de carrera de Dominik Höchli
Antiguos cargos conocidos de Dominik Höchli.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AbbVie AG | Corporate Officer/Principal | - | - |
Formación de Dominik Höchli.
| University of Bern | Doctorate Degree |
Estadísticas
Internacional
| Suiza | 4 |
| Países Bajos | 2 |
Operativa
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Sectorial
| Consumer Services | 2 |
| Health Technology | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MOLECULAR PARTNERS AG | Health Technology |
| Empresas privadas | 2 |
|---|---|
| AbbVie AG | |
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Commercial Services |
- Bolsa de valores
- Insiders
- Dominik Höchli
- Experiencia
